Inosine
Spezifikationen
58-63-9CAS-Nummer
200-390-4EG-Nummer
9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-oneIUPAC-Name
C10H12N4O5Chemische Formel
268.23 g/molMolekulargewicht
inosine; 58-63-9; Hypoxanthosine; Ribonosine; Atorel; Oxiamin; Hypoxanthine riboside; Trophicardyl; Selfer; 9-beta-D-Ribofuranosylhypoxanthine; Hypoxanthine D-riboside; Hypoxanthine ribonucleoside; Hypoxanthine nucleoside; Inosina; Inosinum; Inotin; INO 495; DTXSID2045993; 5A614L51CT; NSC-20262; 9-beta-D-ribofuranosyl-9H-purin-6-ol; DTXCID0025993; CHEBI:17596; 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one; 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one; 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-3H-purin-6-one; 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-1H-purin-6-one; 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6,9-dihydro-1H-purin-6-one; 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6,9-dihydro-3H-purin-6-one; RefChem:791048; D06BB05; G01AX02; S01XA10; 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-3H-purin-6-one; 200-390-4; Panholic-L; Pantholic-L; (-)-Inosine; Inosie; iso-prinosine; Inosine [INN:JAN]; Inosinum [INN-Latin]; Inosina [INN-Spanish]; hypoxanthine-ribose; INO; MFCD00066770; Hypoxanthine, 9-beta-D-ribofuranosyl-; Inosin; AI3-52241; HXR; Hypoxanthine-9-beta-D-ribofuranoside; NSC 20262; beta-D-Ribofuranoside, hypoxanthine-9; Hypoxanthine 9-beta-D-ribofuranoside; MLS000028518; 9.beta.-D-Ribofuranosylhypoxanthine; 1,9-Dihydro-9-beta-D-ribofuranosyl-6H-purin-6-one; 9-.beta.-D-Ribofuranosylhypoxanthine; SMR000058316; 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one; .beta.-Inosine; 9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3H-purin-6(9H)-one; CAS-58-63-9; SR-01000721862; EINECS 200-390-4; Carnine; Catacol; Hypoxanthosine;; NSC20262; Trophicardyl;; UNII-5A614L51CT; Oxiamine;; 3h-inosine; D-Inosine; Inosie;; 2ada; 2fqw; .beta.-D-Ribofuranoside, hypoxanthine-9; NCGC00095787-01; Adenosine Imp. G (EP); Inosine; Didanosine Imp. B (Ph. Int.); 9-beta-D-Ribofuranosyl-1,9-dihydro-6H-purin-6-one; Adenosine Impurity G; Didanosine Impurity B; Hypoxanthine, 9-.beta.-D-ribofuranosyl-; Inotin (TN); Hypoxanthine riboside;; CID 5274258; Inosine (JAN/INN); 1a4m; Inosine (8CI,9CI); INOSINE [INN]; INOSINE [JAN]; INOSINE [MI]; INOSINE [MART.]; Opera_ID_1628; INOSINE [WHO-DD]; INOSINE [WHO-IP]; bmse000098; bmse000888; bmse000978; cid_6021; CHEMBL1556; SCHEMBL15804; KBioGR_002560; KBioSS_002569; INOSINE [USP IMPURITY]; GTPL4554; orb1224575; orb1310617; orb3025449; SCHEMBL1682742; SCHEMBL3365586; SCHEMBL6933022; 9-b-D-Ribofuranosylhypoxanthine; Hypoxanthine-9-D-ribofuranoside; Inosine, >=99% (HPLC); SCHEMBL18653532; 9beta-D-Ribofuranosylhypoxanthine; BDBM22104; KBio2_002560; KBio2_005128; KBio2_007696; KBio3_003038; 9-|A-D-Ribofuranosylhypoxanthine; 9-b-D-ribofuranosyl-Hypoxanthine; MSK6812; 9-|_-D-Ribofuranosylhypoxanthine; cMAP_000084; HMS2235I17; Hypoxanthine-9-delta-ribofuranoside; 9-beta-D-ribofuranosyl-Hypoxanthine; HY-N0092; 9beta-delta-Ribofuranosylhypoxanthine; Tox21_111522; BDBM50366815; beta-D-Ribofuranoside hypoxanthine-9; EBC-44242; EBC-47437; hypoxanthine-9 beta-D-Ribofuranoside; 9-beta-delta-Ribofuranosylhypoxanthine; (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-hydroxypurin-9-yl)oxolane-3,4-diol; AKOS015969695; AKOS015995607; AKOS024462561; Atorel; HXR; Hypoxanthine D-riboside; Tox21_111522_1; 9-beta-delta-ribofuranosyl-Hypoxanthine; CCG-267127; CS-5845; DB04335; DIDANOSINE IMPURITY B [WHO-IP]; NI06297; 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3H-purin-6-one; beta-delta-Ribofuranoside hypoxanthine-9; Hypoxanthine 9-beta-delta-ribofuranoside; hypoxanthine-9 beta-delta-Ribofuranoside; Hypoxanthine-9-beta-delta-ribofuranoside; SMP1_000165; NCGC00095787-05; NCGC00095787-06; NCGC00096119-02; NCGC00096119-03; AS-11754; BP-51105; SY005000; 9-(beta-D-ribofuranosyl)-9H-purin-6-ol; ADENOSINE IMPURITY G [EP IMPURITY]; DB-029916; DIDANOSINE IMPURITY B [EP IMPURITY]; I0037; NS00010210; C00294; D00054; EN300-310328; 1,9-dihydro-9-b-D-ribofuranosyl-6H-Purin-6-one; I538583; Q422564; SR-01000721862-2; SR-01000721862-3; AC89F8E4-FD89-45EE-8B41-94DFC07AB42F; BRD-K79612754-001-19-1; BRD-K79612754-001-21-7; 1,9-Dihydro-9-beta-delta-ribofuranosyl-6H-purin-6-one; 6H-Purin-6-one, 1,9-dihydro-9-beta-D-ribofuranosyl-; Z2681890654; Inosine; Adenosine EP Impurity G; Didanosine EP Impurity B; 9-.BETA.-D-RIBOFURANOSYL-1,9-DIHYDRO-6H-PURIN-6-ONE; 9-beta-D-Ribofuranosyl-1,9-dihydro-6H-purin-6-one (Inosine); 9-.BETA.-D-RIBOFURANOSYL-1,9-DIHYDRO-6H-PURIN-6-ONE [WHO-IP]; (2R,3R,4S,5R)-2-(6-hydroxy-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-3,4-diol; 9-(3,4-DIHYDROXY-5-HYDROXYMETHYL-TETRAHYDRO-FURAN-2-YL)-1,9-DIHYDRO-PURIN-6-ONE; 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-purin-6-one; 478182-32-0; 9-|A-D-Ribofuranosylhypoxanthine; 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one; InChI=1/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/sSynonyme
Produkte, die Inosine enthalten
Unternehmen, die Inosine verkaufen
HD
Hangzhou Dingyan Chem Co., LtdChinaSI
Sinoway Industrial Co.Ltd.ChinaKC
KIVIPHARM CO.,LTD.ChinaCP
CISEN PHARMACEUTICAL CO.,LTD.ChinaZC
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.ChinaHS
Hainan Shuangcheng Pharmaceuticals Co.,Ltd.ChinaTP
Tuoxin Pharmaceutical group Co., LtdChinaCI
China Isotope Development Co.,LtdChinaAC
AFINE CHEMICALS LIMITED